Leading Cancer Groups Chart the Future of Disparities Research
Four leading national cancer organizations have released a joint statement outlining a strategy to help all cancer patients benefit from cancer research, regardless of race, ethnicity, age, gender, sexual orientation, socioeconomic status, or where they live.
Head and Neck Cancer Survivor Advocates for HPV Vaccination
When Cheryl Stark, 50, learned she had head and neck cancer, she didn’t want to talk about it. Her doctor told her the cancer likely came from the human papilloma virus (HPV).
FDA Approves Nerlynx (Neratinib) for a type of Breast Cancer
The US Food and Drug Administration (FDA) has approved the first extended adjuvant therapy for early-stage, HER2-postive breast cancer.
Panel Backs CAR T-cell Therapy for Leukemia: What You Need to Know and What’s Next
The US and Drug Administration (FDA) this week convened a panel of outside experts to weigh in on the readiness of a first-of-its-kind cancer treatment called CAR T-cell therapy. The panel unanimously recommended that the agency approve the treatment. What does this mean for patients? And is CAR T-cell therapy going to play an increasing role in cancer treatment in general? In this interview, Leonard Lichtenfeld, MD, MACP, American Cancer Society deputy chief medical officer, gives us his take.